Literature DB >> 22020172

Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.

Y T Kim1, S W Kang, K H Bai.   

Abstract

OBJECTIVE: To assess the change in the choroidal thickness of the unaffected eyes in patients with unilateral central serous chorioretinopathy (CSC).
METHODS: Thirty eyes with unilateral idiopathic CSC and 30 age-matched normal eyes were included in this study. Choroidal thickness was evaluated from images obtained by enhanced depth image optical coherence tomography. The choroidal thicknesses of the affected eyes, unaffected eyes, and normal eyes were analyzed. Choroidal vascular dilation and hyperpermeability on indocyanine green angiography (ICGA) were analyzed and correlated with the changes in choroidal thickness.
RESULTS: The mean choroidal thicknesses of the affected eyes, unaffected fellow eyes, and normal individuals were 445.58±100.25, 378.35±117.44, and 266.80±55.45 μm, respectively. Compared with normal eyes, subfoveal choroidal thickness was increased significantly in the eyes with active CSC and in the unaffected fellow eyes (P<0.001 in both groups). The choroidal thickness was significantly greater in the eyes with active CSC than in the unaffected fellow eyes (P=0.003). ICGA revealed choroidal vascular hyperpermeability in 28 (93.3%) eyes with CSC and in 23 (73.3%) unaffected fellow eyes. Choroidal vascular dilation was detected in 21 (70.0%) eyes with CSC and in 18 (60.0%) unaffected fellow eyes.
CONCLUSION: Increased choroidal thickness in patients with unilateral CSC was noted not only in the affected eyes, but also in the unaffected fellow eyes. The results of this study suggest that CSC might be an essentially bilateral disorder.

Entities:  

Mesh:

Year:  2011        PMID: 22020172      PMCID: PMC3234484          DOI: 10.1038/eye.2011.258

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  23 in total

1.  The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography.

Authors:  Sushma K Vance; Yutaka Imamura; K Bailey Freund
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

2.  Pathogenesis of central serous retinopathy: a new working hypothesis.

Authors:  M Spitznas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

3.  Pathogenesis of disciform detachment of the neuroepithelium.

Authors:  J D Gass
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

4.  Central serous chorioretinopathy in younger and older adults.

Authors:  R F Spaide; L Campeas; A Haas; L A Yannuzzi; Y L Fisher; D R Guyer; J S Slakter; J A Sorenson; D A Orlock
Journal:  Ophthalmology       Date:  1996-12       Impact factor: 12.079

5.  Central serous chorioretinopathy and white subretinal exudation during pregnancy.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1991-05

6.  Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy.

Authors:  T Iida; S Kishi; N Hagimura; K Shimizu
Journal:  Retina       Date:  1999       Impact factor: 4.256

7.  Digital indocyanine green videoangiography of central serous chorioretinopathy.

Authors:  D R Guyer; L A Yannuzzi; J S Slakter; J A Sorenson; A Ho; D Orlock
Journal:  Arch Ophthalmol       Date:  1994-08

8.  Risk factors for central serous chorioretinopathy: a case-control study.

Authors:  Robert Haimovici; Sean Koh; David R Gagnon; Todd Lehrfeld; Sarah Wellik
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

9.  New hypotheses on the pathogenesis and treatment of serous retinal detachment.

Authors:  M F Marmor
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

10.  Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy.

Authors:  J D Gass; H Little
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

View more
  53 in total

Review 1.  Enhanced depth imaging-OCT of the choroid: a review of the current literature.

Authors:  H Laviers; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-04       Impact factor: 3.117

2.  Correlation of subretinal fluid volume with choroidal thickness and macular volume in acute central serous chorioretinopathy.

Authors:  A Goktas
Journal:  Eye (Lond)       Date:  2014-09-19       Impact factor: 3.775

3.  Axial length in unilateral idiopathic central serous chorioretinopathy.

Authors:  Hoseok Moon; Dae Yeong Lee; Dong Heun Nam
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

4.  Comparison of photodynamic therapy and navigated microsecond laser for chronic central serous chorioretinopathy.

Authors:  Cyprian Gabriel Ntomoka; Bindu Rajesh; Gachago Muchai Muriithi; Abhilash Goud; Jay Chhablani
Journal:  Eye (Lond)       Date:  2018-02-12       Impact factor: 3.775

5.  Polypoidal choroidal vasculopathy and history of central serous chorioretinopathy.

Authors:  T Toyama; K Ohtomo; Y Noda; T Ueta
Journal:  Eye (Lond)       Date:  2014-06-13       Impact factor: 3.775

6.  Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Helena Vasconcelos; Inês Marques; A Rita Santos; Pedro Melo; Isabel Pires; João Figueira; José Faria de Abreu; M Luz Cachulo; Rufino Silva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-07       Impact factor: 3.117

7.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

8.  Variability of subfoveal choroidal thickness measurements in patients with age-related macular degeneration and central serous chorioretinopathy.

Authors:  J H Kim; S W Kang; J R Kim; S J Kim
Journal:  Eye (Lond)       Date:  2013-04-19       Impact factor: 3.775

9.  Change in subfoveal choroidal thickness in central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy.

Authors:  N H Kang; Y T Kim
Journal:  Eye (Lond)       Date:  2013-01-04       Impact factor: 3.775

10.  Evaluation of nailfold videocapillaroscopy in central serous chorioretinopathy.

Authors:  Muhammet Kazim Erol; Ayse Balkarli; Devrim Toslak; Berna Dogan; Dogan Durmaz; Elçin Süren; Salih Altun; Mehmet Bulut; Veli Cobankara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-19       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.